L&C BIO · [기재정정]기업설명회(IR)개최
Amended Filing (Report)
| Correction Date | 2026-11-17 |
| 1. Disclosure Document Subject to Correction | Investor Relations (IR) Meeting | |
| 2. Filing Date of Document Subject to Correction | 2026-11-17 | |
| 3. Reason for Correction | 단순 오기 | |
| 4. Corrections | ||
| Corrected Item | Before Correction | After Correction |
| 5. Method | 1) 유안타증권 (1) 행사명: NDR (2) 일정: 2026.11.16(화) ~ 2026.11.17(수) | 1) 유안타증권 (1) 행사명: NDR (2) 일정: 2026.11.17(화) ~ 2026.11.18(수) |
| - |
Investor Relations (IR) Meeting
| 1. Date and Time | Exercise date | Time (local time) | |
| Start Date | End Date | Start time | End time |
| 2026-11-17 | 2026-11-27 | 09:00 | 15:30 |
| 2. Venue | 서울 여의도 등 | ||
| 3. Subject | Domestic institutional investors | ||
| 4. Purpose | 국내 NDR 참가 | ||
| 5. Method | 1:1 및 그룹 미팅 1) 유안타증권 | ||
(1) 행사명: NDR
(2) 일정: 2026.11.17(화) ~ 2026.11.18(수) 2) LS증권
(1) 행사명: NDR
(2) 일정: 2026.11.26(목) ~ 2026.11.27(금) |
| 6. Key details | 1. 2026년 3분기 경영실적 설명 2. 질의응답(Q&A) |
| 7. Sponsoring Institution | 유안타증권, LS증권 |
| 8. Confirmed Meeting Date | 2026-11-16 |
| 9. Contact person | Department (Contact Person) | (주)엘앤씨바이오 경영관리팀 이종찬 과장 |
| Phone (Fax) | 070-7733-8358 |
| 10. IR Materials Posting | Posting Date/Time | 2026-11-16 |
| Place of Publication | https://www.lncbio.co.kr/ |